Financial Partners Group (Kansas)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,251
| Closed | -$306K | – | 177 |
|
|
2023
Q4 | $306K | Hold |
2,251
| – | – | 0.05% | 128 |
|
|
2023
Q3 | $259K | Sell |
2,251
-110
| -5% | -$12.6K | 0.05% | 130 |
|
|
2023
Q2 | $301K | Sell |
2,361
-36
| -2% | -$4.59K | 0.06% | 120 |
|
|
2023
Q1 | $310K | Sell |
2,397
-52
| -2% | -$6.72K | 0.07% | 119 |
|
|
2022
Q4 | $329K | Buy |
+2,449
| New | +$329K | 0.07% | 120 |
|
|
2022
Q2 | – | Sell |
-2,356
| Closed | -$307K | – | 159 |
|
|
2022
Q1 | $307K | Sell |
2,356
-28,818
| -92% | -$3.76M | 0.07% | 129 |
|
|
2021
Q4 | $4.11M | Buy |
31,174
+609
| +2% | +$80.3K | 0.9% | 28 |
|
|
2021
Q3 | $4.94M | Sell |
30,565
-605
| -2% | -$97.8K | 1.16% | 23 |
|
|
2021
Q2 | $5.1M | Sell |
31,170
-14,400
| -32% | -$2.36M | 1.31% | 20 |
|
|
2021
Q1 | $6.86M | Sell |
45,570
-816
| -2% | -$123K | 1.95% | 15 |
|
|
2020
Q4 | $7.59M | Sell |
46,386
-2,272
| -5% | -$372K | 2.27% | 15 |
|
|
2020
Q3 | $6.59M | Sell |
48,658
-562
| -1% | -$76.1K | 2.26% | 15 |
|
|
2020
Q2 | $6.73M | Buy |
49,220
+15,578
| +46% | +$2.13M | 2.63% | 13 |
|
|
2020
Q1 | $3.49M | Buy |
33,642
+1,892
| +6% | +$196K | 2.16% | 15 |
|
|
2019
Q4 | $3.73M | Sell |
31,750
-171
| -0.5% | -$20.1K | 1.45% | 18 |
|
|
2019
Q3 | $3.18M | Buy |
+31,921
| New | +$3.18M | 1.41% | 19 |
|
|
2019
Q2 | – | Sell |
-25,802
| Closed | -$2.89M | – | 80 |
|
|
2019
Q1 | $2.89M | Sell |
25,802
-9,371
| -27% | -$1.05M | 1.56% | 21 |
|
|
2018
Q4 | $3.39M | Buy |
35,173
+1,889
| +6% | +$182K | 2.21% | 15 |
|
|
2018
Q3 | $4.06M | Sell |
33,284
-607
| -2% | -$74K | 2.65% | 13 |
|
|
2018
Q2 | $3.72M | Buy |
33,891
+398
| +1% | +$43.7K | 2.73% | 11 |
|
|
2018
Q1 | $3.58M | Sell |
33,493
-679
| -2% | -$72.5K | 2.8% | 13 |
|
|
2017
Q4 | $3.65M | Buy |
+34,172
| New | +$3.65M | 2.88% | 13 |
|